In the face of the future, what do we learn from COVID-19?
Coronavirus disease (COVID-19) is a highly contagious infection caused by a recently identified coronavirus. The first known case was discovered in December 2019 in Wuhan, China. Since then, the illness has spread globally, resulting in an ongoing epidemic. Here, we would like to address one of the...
Main Authors: | Amr Ahmed EL-Arabey, Mohnad Abdalla |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2021.1963174 |
Similar Items
-
Human Coronavirus Spike Protein Based Multi-Epitope Vaccine against COVID-19 and Potential Future Zoonotic Coronaviruses by Using Immunoinformatic Approaches
by: Zulqarnain Baloch, et al.
Published: (2022-07-01) -
Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021-10-01) -
COVID-19 vaccine development: What lessons can we learn from TB?
by: Hussain A. Safar, et al.
Published: (2020-11-01) -
Vasculitis and COVID-19: what do we have to know?
by: Antonio Tamburello, et al.
Published: (2020-12-01) -
Do we need to vaccinate every child against COVID-19: What evidence suggests—A systematic review of opinions
by: Sourabh Paul, et al.
Published: (2022-11-01)